Evidence map›Paper›PMID 21071415›Full record

ArticleNucleic acids research2011

Genome-wide detection of a TFIID localization element from an initial human disease mutation.

Mary Q Yang, Karina Laflamme, Valer Gotea, Clinton H Joiner, Nancy E Seidel, Clara Wong, Hanna M Petrykowska, Jens Lichtenberg, Stephen Lee, Lonnie Welch and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Mary Q YangGenome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Rockville, MD 20852, USA.
Karina Laflamme
Valer Gotea
Clinton H Joiner
Nancy E Seidel
Clara Wong
Hanna M Petrykowska
Jens Lichtenberg
Stephen Lee
Lonnie Welch
Patrick G Gallagher
David M Bodine
Laura Elnitski
National Human Genome Research Institute · USNational Institutes of Health · USOhio University · USCincinnati Children's Hospital Medical Center · US

Funding

Regulatory and epigenetic landscapes reveal biological processes, disease mechanisms and diagnostic markersZIAHG200323 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI ELNITSKI, LAURA L · 2009 to 2025
$27.6M
Hematopoietic Stem Cell BiologyZIAHG000083 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI BODINE, DAVID M. · 2009 to 2022
$12.1M
Red Cell BiologyZIAHG200339 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI BODINE, DAVID M. · 2009 to 2022
$11.8M
High Efficiency Dialyzer Development - Phase 2R44DK060239 · NIDDK · ENSION, INC. · PI GARTNER, MARK · 2005 to 2006
$825k
High Efficiency Dialyzer DevelopmentR43DK060239 · NIDDK · ENSION, INC. · PI LITWAK, PHILIP · 2001 to 2001
$100k
Intramural NIH HHSNIDDK NIH HHS DK04015NIDDK NIH HHS DK60239
6 · The paper itself

Abstract

Eukaryotic core promoters are often characterized by the presence of consensus motifs such as the TATA box or initiator elements, which attract and direct the transcriptional machinery to the transcription start site. However, many human promoters have none of the known core promoter motifs, suggesting that undiscovered promoter motifs exist in the genome. We previously identified a mutation in the human Ankyrin-1 (ANK-1) promoter that causes the disease ankyrin-deficient Hereditary Spherocytosis (HS). Although the ANK-1 promoter is CpG rich, no discernable basal promoter elements had been identified. We showed that the HS mutation disrupted the binding of the transcription factor TFIID, the major component of the pre-initiation complex. We hypothesized that the mutation identified a candidate promoter element with a more widespread role in gene regulation. We examined 17,181 human promoters for the experimentally validated binding site, called the TFIID localization sequence (DLS) and found three times as many promoters containing DLS than TATA motifs. Mutational analyses of DLS sequences confirmed their functional significance, as did the addition of a DLS site to a minimal Sp1 promoter. Our results demonstrate that novel promoter elements can be identified on a genome-wide scale through observations of regulatory disruptions that cause human disease.

Indexed as

MutationPromoter Regions, GeneticAnkyrinsBase SequenceBinding SitesConsensus SequenceGenome, HumanHumansK562 CellsSpherocytosis, HereditaryTranscription Factor TFIIDTranscription Initiation SiteANK1 protein, humanAnkyrinsTranscription Factor TFIID

Identifiers

PMID21071415
PMCPMC3064768
OpenAlexW2124009776

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.